M.D. Seftel
M.D. Seftel publishes mostly in Hematology, Public Health, Environmental and Occupational Health and Oncology, on topics such as Acute Lymphoblastic Leukemia research, Multiple Myeloma Research and Treatments and Chronic Myeloid Leukemia Treatments.
- World rank
- #5,067,717 of 7,710,434 ranked researchers
- Rank in Canada
- #148,778 of 183,316
- Works
- 15
- Citations
- 384
- Citations per work
- 25.6
What does M.D. Seftel research?
M.D. Seftel's work is mostly in Medicine (65%), Chemistry (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1065.0%
- Medicine1065.0%
- Everything else427.5%
- Physical Sciences17.5%
- Chemistry17.5%
- 1Hematology25% of their works
- 2Public Health, Environmental and Occupational Health18% of their works
- 3Oncology8% of their works
- 4Pathology and Forensic Medicine8% of their works
- 5Organic Chemistry8% of their works
- 6Genetics8% of their works
Research topics
Which keywords describe M.D. Seftel's research?
The keywords of their largest research topics: Prognostic Factors, Minimal Residual Disease, Rituximab, Acute Lymphoblastic Leukemia, Childhood Cancer, Hematopoietic Stem Cells, BCR-ABL and Classification.
- Mortality Rates
- Genomic Aberrations
- Cancer Incidence
- Acute Myeloid Leukemia
- Lymphoma
- Imatinib
- Classification
- Hematopoietic Stem Cells
- Acute Lymphoblastic Leukemia
- Minimal Residual Disease
- Prognostic Factors
- Rituximab
- Childhood Cancer
- BCR-ABL
- Diagnosis Criteria
- International Myeloma Working Group
- AML
- Bone Marrow Niche
- Chronic Lymphocytic Leukemia
- Graft-versus-Host Disease
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Factors83 topics
- Minimal Residual Disease72 topics
- Rituximab52 topics
- Acute Lymphoblastic Leukemia41 topic
- Childhood Cancer41 topic
- Hematopoietic Stem Cells42 topics
- BCR-ABL31 topic
- Classification31 topic
- Diagnosis Criteria31 topic
- Imatinib31 topic
- International Myeloma Working Group31 topic
- Lymphoma31 topic
- AML21 topic
- Acute Myeloid Leukemia21 topic
- Bone Marrow Niche21 topic
- Cancer Incidence21 topic
- Chronic Lymphocytic Leukemia21 topic
- Genomic Aberrations21 topic
- Graft-versus-Host Disease21 topic
- Mortality Rates21 topic
Where does M.D. Seftel work?
M.D. Seftel's main affiliation in the publication record is CancerCare Manitoba, Canada.
How many publications and citations does M.D. Seftel have?
OpenAlex counts 15 works and 384 citations for M.D. Seftel, an h-index of 5, ranking #5,067,717 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about M.D. Seftel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.